WO2009041449A1 - 抗肥満剤 - Google Patents

抗肥満剤 Download PDF

Info

Publication number
WO2009041449A1
WO2009041449A1 PCT/JP2008/067218 JP2008067218W WO2009041449A1 WO 2009041449 A1 WO2009041449 A1 WO 2009041449A1 JP 2008067218 W JP2008067218 W JP 2008067218W WO 2009041449 A1 WO2009041449 A1 WO 2009041449A1
Authority
WO
WIPO (PCT)
Prior art keywords
antiobesity agent
food
drug
active ingredient
reduced coenzyme
Prior art date
Application number
PCT/JP2008/067218
Other languages
English (en)
French (fr)
Inventor
Kazuya Hamada
Hideyuki Kishida
Original Assignee
Kaneka Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corporation filed Critical Kaneka Corporation
Publication of WO2009041449A1 publication Critical patent/WO2009041449A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

　本発明の目的は、肥満を改善または予防することのできる、より安全ですぐれた抗肥満剤を提供することである。本発明は、還元型補酵素Ｑを有効成分とする抗肥満剤、および、該抗肥満剤を含有する、医薬品、医薬部外品、食品、保健機能食品、特定保健用食品、化粧料、動物用医薬品、ペットフード、または飼料である。さらに本発明は、該還元型補酵素Ｑを有効成分とする抗肥満剤を、投与対象に投与することを含む肥満のコントロール方法でもある。
PCT/JP2008/067218 2007-09-25 2008-09-25 抗肥満剤 WO2009041449A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-247000 2007-09-25
JP2007247000 2007-09-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/782,813 Continuation US8264161B2 (en) 2007-11-20 2010-05-19 Lighting apparatus for high-voltage discharge lamp

Publications (1)

Publication Number Publication Date
WO2009041449A1 true WO2009041449A1 (ja) 2009-04-02

Family

ID=40511332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/067218 WO2009041449A1 (ja) 2007-09-25 2008-09-25 抗肥満剤

Country Status (1)

Country Link
WO (1) WO2009041449A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172346A (ja) * 2017-03-31 2018-11-08 株式会社東洋新薬 妊娠サポート用組成物
WO2020067125A1 (ja) * 2018-09-25 2020-04-02 宏輝システムズ株式会社 飼料添加剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006085562A1 (ja) * 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
WO2008035757A1 (fr) * 2006-09-22 2008-03-27 Kaneka Corporation Aliment de type gelée contenant de l'ubiquinol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006085562A1 (ja) * 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
WO2008035757A1 (fr) * 2006-09-22 2008-03-27 Kaneka Corporation Aliment de type gelée contenant de l'ubiquinol

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CELIK, S. ET AL.: "Effects of intraperitoneally administered ubiquinone on the level of total lipid and fatty acids in rat liver", CELL BIOCHEMISTRY AND FUNCTION, vol. 24, no. 6, 2006, pages 561 - 564 *
FURUKAWA, S. ET AL.: "Increased oxidative stress in obesity and its impact on metabolic syndrome", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 114, no. 12, 2004, pages 1752 - 1761 *
YOSHIDA, T., ANTIOBESITY AGENTS: THE PRESENT AND THE EMERGING ONES IN JAPAN, EUROPE AND USA, NIPPON RINSHO, vol. 61, no. 6, 2003, pages 649 - 654 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172346A (ja) * 2017-03-31 2018-11-08 株式会社東洋新薬 妊娠サポート用組成物
WO2020067125A1 (ja) * 2018-09-25 2020-04-02 宏輝システムズ株式会社 飼料添加剤
RU2768392C1 (ru) * 2018-09-25 2022-03-24 Коки Системз Ко., Лтд. Кормовая добавка, способ и применение экстракта солодки для улучшения качества эмбрионов

Similar Documents

Publication Publication Date Title
WO2008093793A1 (ja) 口腔内乾燥症の緩和または予防剤
WO2011107755A3 (en) Immediate/delayed drug delivery
WO2008016811A3 (en) Aminopiperidines and realted compounds
WO2011107749A3 (en) Pulsatile drug release
WO2009055331A3 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
WO2010106457A3 (en) 3-oxa-7-azabicyclo[3.3.1]nonanes
WO2010002283A3 (en) New insulin analogues of prolonged activity
UA111464C2 (uk) Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу
MX2011011178A (es) Compuesto de diaciletilendiamina.
WO2008120713A1 (ja) 副交感神経活動亢進作用を有する医薬組成物又は飲食物
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
EP2497467A4 (en) PHARMACEUTICAL COMBINATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICAMENT THEREFOR AND METHOD FOR TREATING ANIMALS
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
EP2438923A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY-RELATED DISORDERS MEDIATED BY AMPK ACTIVATION AND THE ACTIVE INGREDIENTS OF WHICH HAVE 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2007098964A3 (en) Pyrrazole derivatives as sigma receptors antagonists
WO2009023299A3 (en) Anti-angiogenic agents and methods of use
WO2011056871A3 (en) Rhamnolipid mechanism
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
WO2012106058A3 (en) Animal treatments
WO2011014520A3 (en) Compounds and compositions as modulators of gpr119 activity
MY157007A (en) Novel possibility of controlling giardiosis
WO2009041449A1 (ja) 抗肥満剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08833670

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 08833670

Country of ref document: EP

Kind code of ref document: A1